Search
for
Sort by
Research 61–90 of 1000+
- The association of androgenetic alopecia and insulin resistance is independent of hyperandrogenemia: A case-control study
- Retinol-binding protein 4, leptin, and insulin resistance in idiopathic hirsutism and hirsute women with polycystic ovary syndrome
- Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
- Insulin Resistance and Skin Diseases
- Alopecia androgenética en varones jóvenes: un indicador clínico temprano de resistencia a la insulina
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome
- The relationship among androgens, insulin resistanceand ghrelin polymorphisms in post-adolescent malepatients with severe acne vulgaris
- Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
- Prevalence of Clinical Manifestations Known to Be Associated With Insulin Resistance Among Female Medical Students of a Private College in Saudi Arabia
- Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance
- Role of Insulin Resistance and Oxidative Stress in Hair Loss
- Insulin Resistance and Polycystic Ovary Syndrome
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature
- Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives
- Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- The effects of pro-, pre- and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials